John Oyler
Chief Executive Officer, Director · BeOne Medicines Ltd.
- 2024
- Aug 12, 2026
- 19
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John Oyler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Xiaodong Wang - $24.68M in ONC purchases and sales in the last 12 months
- Xiaobin Wu - $8.75M in ONC purchases and sales in the last 12 months
- Chan Henry Lee - $4.20M in ONC purchases and sales in the last 12 months
- Lai Wang - $1.17M in ONC purchases and sales in the last 12 months
- Corazon (Corsee) D. Sanders - $961K in ONC purchases and sales in the last 12 months
- Aaron Rosenberg - $524K in ONC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John Oyler?
John Oyler is a corporate insider, tracked as Chief Executive Officer, Director of BeOne Medicines Ltd. (ONC). InsiderAlpha holds 19 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has John Oyler submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has John Oyler been buying or selling stock?
Recorded transactions: 0 open-market purchases and 97 open-market sales ($212.95M) across all tracked filings.
